Perl A. (2013). Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nature reviews. Rheumatology, 9(11), 674–686. https://doi.org/10.1038/nrrheum.2013.147
Barancik, M., Kura, B., LeBaron, T. W., Bolli, R., Buday, J., & Slezak, J. (2020). Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems. Antioxidants, 9(12), 1281. https://doi.org/10.3390/antiox9121281
Tian, Y., Zhang, Y., Li, X., Wei, Y., Wei, J., & Wei, Y. (2021). Hydrogen, a novel therapeutic molecule, regulates oxidative stress, inflammation, and apoptosis. Frontiers in Physiology, 12, Article 789507. https://doi.org/10.3389/fphys.2021.789507
Ishibashi, T., Sato, B., Rikitake, M., Seo, T., Kurokawa, R., Hara, Y., Naritomi, Y., Hara, H., & Nagao, T. (2012). Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study. Medical gas research, 2(1), 27. https://doi.org/10.1186/2045-9912-2-27
Tu, T. H., Lu, J. W., Wu, C. H., Ho, Y. J., Lui, S. W., Hsieh, T. Y., Wang, K. Y., & Liu, F. C. (2025). Molecular Hydrogen Therapy for SLE-PAH: Case Report on Immune Marker Modulation. In vivo (Athens, Greece), 39(2), 1211–1219. https://doi.org/10.21873/invivo.13926
Lin, Y. T., Lu, J. W., Ho, Y. J., Lui, S. W., Hsieh, T. Y., Wang, K. Y., & Liu, F. C. (2025). Molecular Hydrogen as a Potential Adjunctive Therapy to Improve Renal Function and Reduce Fatigue in an Elderly Patient With Chronic Comorbidities: A Case Report. In vivo (Athens, Greece), 39(1), 572–576. https://doi.org/10.21873/invivo.13862
Xue, J. L., Liu, B. Y., Zhao, M., Zhang, M. Y., Wang, M. Y., Gu, Q. Q., Zhang, X. Y., & Qin, S. C. (2023). Inhalation of 4% and 67% hydrogen ameliorates oxidative stress, inflammation, apoptosis, and necroptosis in a rat model of glycerol-induced acute kidney injury. Medical gas research, 13(2), 78–88. https://doi.org/10.4103/2045-9912.345169
医師
白石暁 先生
水素療法は、さまざま作用機序によってSLEの複数の症状を改善する可能性が示唆されています。まだ大規模な研究結果はありませんが、水素吸入は副作用が少なく安全性が高いと報告されています。通常の治療と併せて実施することで、患者さんの日常生活の質を高める新たな選択肢となると期待が寄せられています。